Comparative Molecular Dynamics Simulation of Hepatitis C Virus NS3/4A Protease (Genotypes 1b, 3a and 4a) Predicts Conformational Instability of the Catalytic Triad in Drug Resistant Strains-Reference-Cited by-同舟云学术

Comparative Molecular Dynamics Simulation of Hepatitis C Virus NS3/4A Protease (Genotypes 1b, 3a and 4a) Predicts Conformational Instability of the Catalytic Triad in Drug Resistant Strains

Published:2014-08-11 Issue:8 Volume:9 Page:e104425
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kramer Mitchell,Halleran Daniel,Rahman Moazur,Iqbal Mazhar,Anwar Muhammad Ikram,Sabet Salwa,Ackad Edward,Yousef Mohammad

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference66 articles.

1. The global burden of hepatitis C;D Levanchy;Liver,2009

2. A wide range of NS3/4A protease catalytic efficiencies in HCV- infected individuals;S Franco;Virus Res,2008

3. HCV genotypes, characterization of mutations conferring drug resistance to protease inhibitors, and risk factors among blood donors in São Paulo, Brazil;AS Nishiya;PLoS One,2014

4. Distribution of hepatitis C virus genotypes in a diverse US integrated health care population;MM Manos;J Medi Virol,2012

5. Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt;FD Miller;Proc Natl Acad Sci USA,2010

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C: The Story of a Long Journey through First, Second, and Third Generation NS3/4A Peptidomimetic Inhibitors. What Did We Learn?;Journal of Medicinal Chemistry;2024-01-05

2. The Inhibitory Potential of 2′-dihalo Ribonucleotides against HCV: Molecular Docking, Molecular Simulations, MM-BPSA, and DFT Studies;Molecules;2022-07-15

3. Finding a prospective dual-target drug for the treatment of coronavirus disease by theoretical study;Journal of Biomolecular Structure and Dynamics;2021-09-13

4. Molecular and Structural Mechanism of Pan-Genotypic HCV NS3/4A Protease Inhibition by Glecaprevir;ACS Chemical Biology;2019-12-23

5. A novel molecular mechanism to explain mutations of the HCV protease associated with resistance against covalently bound inhibitors;Virus Research;2019-12